Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza a virus subtype H3N2 (H3N2v)

Journal of Infectious Diseases

Volumn 206, Issue 12, 2012, Pages 1852-1861

  Skowronski, Danuta M ^a,b   Janjua, Naveed Z ^a,b   De Serres, Gaston ^c,d,e   Purych, Dale ^b,f   Gilca, Vladimir ^c,d,e   Scheifele, David W ^b   Dionne, Marc ^c,d,e   Sabaiduc, Suzana ^a   Gardy, Jennifer L ^a,b   Li, Guiyun ^a   Bastien, Nathalie ^g   Petric, Martin ^a,b   Boivin, Guy ^d,e   Li, Yan ^g  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITÉ LAVAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

^f BC Biomedical Laboratories   (United Kingdom)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; MIFAMURTIDE; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; AUTUMN; BLOOD SAMPLING; CHILD; CONVENIENCE SAMPLE; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION SENSITIVITY; INFLUENZA A (H3N2); INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROCONVERSION; SEROPREVALENCE; STRAIN DIFFERENCE; VIRUS NEUTRALIZATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; SEROEPIDEMIOLOGIC STUDIES; SWINE; UNITED STATES; YOUNG ADULT;

EID: 84870204322     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis500     Document Type: Article

References (49)

1. Reid AH, Fanning TG, Hultin JV, Taubenberger JK. Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene. Proc Natl Acad Sci U S A 1999; 96:1651-6. (Pubitemid 29098506)
2. Easterday BC. Swine influenza: Historical perspectives. In: Proceedings of the 4th International Symposium on Emerging and Re-emerging Pig Diseases (Rome). Parma, Italy: University of Parma, Faculty of Veterinary Medicine, Department of Animal Health, 2003:241-4.http://www.unipr.it/arpa/facvet/dip/ dipsa/ric/prrs2003/. Accessed 23 August 2012.
3. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: A review of the literature. Clin Infect Dis 2007; 44:1084-8. (Pubitemid 46580277)
4. Taubenberger JK, Morens DM. 1918 influenza: The mother of all pandemics. Emerg Infect Dis 2006; 12:15-22. (Pubitemid 43143529)
5. Kanegae Y, Sugita S, Shortridge KF, Yoshioka Y, Nerome K. Origin and evolutionary pathways of the H1 hemagglutinin gene of avian, swine and human influenza viruses: Cocirculation of two distinct lineages of swine virus. Arch Virol 1994; 134:17-28. (Pubitemid 2027012)
6. Zarocostas J. World Health Organization declares A (H1N1) influenza pandemic. BMJ 2009; 338b:b2425.
7. Skowronski DM, Hottes TS, McElhaney JE, et al. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: Higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 2011; 203:158-67.
8. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201.
9. Booy R, Khandaker G, Heron LG, et al. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Med J Aust 2011; 194:19-23.
10. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361:1945-52.
11. Potter CW. Chronicle of influenza pandemics. In: Nicholson KG, Webster KG, Hay A, eds. Textbook of influenza. Oxford, United Kingdom: Blackwell Science, 1998:3-18.
12. Nakajima K, Nakajima S, Shortridge KF, Kendal AP. Further genetic evidence for maintenance of early Hong Kong-like influenza A (H3N2) strains in swine until 1976. Virology 1982; 116:562-72. (Pubitemid 12163308)
13. Scholtissek C, Hinshaw VS, Olsen CW. Influenza in pigs and their role as the intermediate host. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Malden, MA: Blackwell Science, 1998: 137-45.
14. Olsen CW, Karasin AI, Carman S, et al. Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 2006; 12: 1132-5. (Pubitemid 44061286)
15. World Health Organization (WHO). Standardization of terminology for the variant A(H3N2) virus recently infecting humans. Joint Announcement of FAO, OIE and WHO. Geneva: WHO, 2011.http://www.who.int/influenza/gisrs-laboratory/ terminology-ah3n2v/en/index.html. Accessed 23 August 2012.
16. Centers for Disease Control and Prevention. Swine-origin influenza A (H3N2) virus infection in two children - Indiana and Pennsylvania, July-August 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1213-5.
17. Centers for Disease Control and Prevention. Update: Influenza A (H3N2)v transmission and guidelines - five states, 2011. MMWR Morb Mortal Wkly Rep 2012; 60:1741-4.
18. Centers for Disease Control and Prevention. First H3N2 variant virus infection reported for 2012.http://www.cdc.gov/flu/spotlights/h3n2vvariant- utah.htm Accessed 23 August 2012.
19. Pearce MB, Jayaraman A, Pappas C, et al. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A 2012; 109:3944-9.
20. Shu B, Garten R, Emery S, et al. Genetic analysis and antigenic characterization of swine origin influenza viruses isolated from humans in the United States, 1990-2010. Virology 2012; 422:151-60.
21. Lina B, Bouscambert M, Enouf V, et al. S-OtrH3N2 viruses: Use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses. Euro Surveill 2011; 16:pii = 20039.http://www.eurosurveillance.org/ViewArticle.aspx?Articleid=20039. Accessed 23 August 2012.
22. Skowronski DM, De Serres G, Janjua NZ, et al. Cross-reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunization with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro Surveill 2012; 17:pii = 20066.http://www. eurosurveillance.org/View Article.aspx?Articleid=20066. Accessed 23 August 2012.
23. Buck P, Herman S, Scott C, et al. Influenza in Canada - 1997-1998 season. Can Commun Dis Rep 1998; 24-21:169-76.http://www. collectionscanada.gc.ca/ webarchives/20071212051821/http://www.phacaspc. gc.ca/publicat/ccdr-rmtc/98pdf/ cdr2421e.pdf. Accessed 23 August 2012.
24. World Health Organization, Global Alert and Response. Recommendations for influenza vaccine composition. Geneva: WHO.http://www.who.int/influenza/ vaccines/virus/recommendations/en/. Accessed 23 August 2012.
25. Tremblay D, Allard V, Doyon J-F, et al. Emergence of a new swine H3N2 and pandemic (H1N1) 2009 influenza A virus reassortant in two Canadian animal populations, mink and swine. J Clin Microbiol 2011; 49:4386-90. doi:10.1128/JCM.05676-11.
26. Liu Q, Ma J, Liu H, et al. Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Arch Virol 2011; 157:555-62. doi:10.1007/s00705-011- 1203-9.
27. Fan X, Zhu H, Zhou B, et al. Emergence and dissemination of a swine H3N2 reassortant with 2009 pandemic H1N1 genes in pigs in China. J Virol 2012; 86:2375-8. doi:10.1128/JVI.06824-11.
28. Skowronski DM, Hottes TS, Janjua NZ, et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 2010; 182:1851-6.
29. Gilca V, De Serres G, Hamelin M-E, et al. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine 2011; 30:35-41.
30. Scheifele DW, Dionne M, Ward B, et al. Safety and immunogenicity of re-vaccination with H1N1-containing 2010-2011 seasonal influenza vaccine after priming with 2009 adjuvanted pandemic vaccine [abstract S18]. In: Proceedings of the 14th Annual Conference on Vaccine Research, 16-18 May 2011, Baltimore, MD.
31. World Health Organization. Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. 2011.http://whqlibdoc.who.int/publications/2011/9789241548090-eng.pdf. Accessed 23 August 2012.
32. Committee for Proprietary Medicinal Products. Note for guidance on harmonization of requirements for influenza vaccines. CPMP/BWP/214/96(circular no. 96-0666). London: European Agency for the Evaluation of Medicinal Products, 1997:1-22.
33. Barr IG, McCauley J, Cox N, et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2), and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2010; 28:1156-67.
34. Potter CW, Oxford JS. Determinants of immunity to influenza infection in man. Br Med Bull 1979; 35:69-75. (Pubitemid 9096975)
35. BC STATS. Population estimates (1986-2008) and projections (2009- 2036). P.E.O.P.L.E. 34 (July 1): 2009-2036. Victoria, BC: BC Ministry of Citizens' Services, 2009.http://www.bcstats.gov.bc.ca/StatisticsBy Subject/Demography/ PopulationProjections.aspx. Accessed 23 August 2012.
36. Mikolajczyk RT, Akmatov MK, Rastin S, Kretzschmar M. Social contacts of school children and the transmission of respiratory-spread pathogens. Epidemiol Infect 2008; 136:813-22. (Pubitemid 351524016)
37. Nicholson KG. Human influenza. In: Nicholson KG, Webster RG, Hays AJ, eds. Textbook of influenza. Malden, MA: Blackwell Science, 1998:221-6.
38. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA 2004; 292:1333-40. (Pubitemid 39223224)
39. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86. (Pubitemid 36068705)
40. LCDC. Influenza in Canada - 1996-97 season. Can Commun Dis Rep 1997; 23-24:185-92.http://www.collectionscanada.gc.ca/webarchives/20071212051751/http: //www.phac-aspc.gc.ca/publicat/ccdr-rmtc/97pdf/cdr2324e.pdf. Accessed 23 August 2012.
41. Reyes F, Aziz S, Li Y, et al. Influenza in Canada: 2006-2007 season. Can Commun Dis Rep 2008; 34: 1-25.http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/ 08pdf/cdr3403.pdf. Accessed 23 August 2012.
42. Dowdle WR. Influenza A virus recycling revisited. Bull World Health Organ 1999; 77:820-8.
43. Morens DM, Burke DS, Halstead SB. The wages of original antigenic sin. Emerg Infect Dis 2010; 16:1023-4.
44. de Jong JC, Palache AM, Beyer WEP, et al. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003; 115:63-73.
45. Montomoloi E. Correlates of protection against influenza. In: Rappuoli R, Del Guidce G, eds. Influenza vaccines for the future. Basel, Switzerland: Birhauser Verlag, 2008:139-59.
46. Ansaldi F, Bacilieri S, Banfi F, et al. Neutralizing and hemagglutinationinhibiting activities of antibodies elicited by the 2004-2005 influenza vaccine against drifted viruses. Clin Vaccine Immunol 2006; 13:162-4.
47. Centers for Disease Control and Prevention (CDC). Antibodies crossreactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccine on cross-reactive antibodies - United States. MMWR Morb Mortal Wkly Rep 2012; 61:237-41.
48. Waalen K, Kilander A, Dudman S, Ramos-Ocao R, Hungnes O. Agedependent prevalence of antibodies cross-reactive to the influenza A (H3N2) variant virus in sera collected in Norway in 2011. Euro Surveill 2012; 17:Pii:20170.http:// www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20170. Accessed 23 August 2012.
49. Influenza Immunization Coverage by Province and age 2007-08 In: Table 105-0502. Health indicator profile, annual estimates, by age group and sex, Canada, provinces, territories, health regions (2007 boundaries) and peer groups, occasional (1209600 series). Ottawa, Canada: Statistics Canada (2009).